Device Trial Radar · NCT07525518
Okami Medical ALPHA Registry
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
500
Planned (sponsor's estimate)
Start
Mar 31, 2026
Primary completion
Aug 2030
Study completion Aug 2030
Sponsor
- Lead sponsor
- Okami Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 13, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.
Conditions
- Arterial Bleed
- Pulmonary Arteriovenous Malformation
- Embolization
- Hemorrhage
Interventions
LOBO Vascular Occlusion SystemDevice
LOBO Vascular Occlusion System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety EndpointTime frame: 30 days post-index procedure
1 more outcomes with a free account
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Stanford University
Stanford, California
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.